TY - JOUR
T1 - Bio and nanotechnological strategies for tumor-targeted gene therapy
AU - Kang, Jeong Hun
AU - Toita, Riki
AU - Katayama, Yoshiki
N1 - Funding Information:
This work was financially supported by the Japan Science Corporation , and a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture in Japan .
PY - 2010/11
Y1 - 2010/11
N2 - Gene therapy is a new medical approach for the treatment of tumors. For safe and efficient gene therapy, therapeutic genes need to be delivered efficiently into the target tumor cells. Development of gene delivery systems to specifically recognize and target tumor cells and to distinguish them from normal cells, especially in the same tissue or organ, is one of the most important issues regarding the present gene delivery methodologies. The enhanced permeability and retention (EPR) effect using the characteristics of angiogenic tumor blood vessels, as well as gene delivery systems recognizing hyperactivated receptors or intracellular signals, is broadly applied to tumor-targeted gene therapy. In addition, bacterial vectors can be a useful means for targeting hypoxic or anoxic regions of a tumor.
AB - Gene therapy is a new medical approach for the treatment of tumors. For safe and efficient gene therapy, therapeutic genes need to be delivered efficiently into the target tumor cells. Development of gene delivery systems to specifically recognize and target tumor cells and to distinguish them from normal cells, especially in the same tissue or organ, is one of the most important issues regarding the present gene delivery methodologies. The enhanced permeability and retention (EPR) effect using the characteristics of angiogenic tumor blood vessels, as well as gene delivery systems recognizing hyperactivated receptors or intracellular signals, is broadly applied to tumor-targeted gene therapy. In addition, bacterial vectors can be a useful means for targeting hypoxic or anoxic regions of a tumor.
UR - http://www.scopus.com/inward/record.url?scp=77957021160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957021160&partnerID=8YFLogxK
U2 - 10.1016/j.biotechadv.2010.06.001
DO - 10.1016/j.biotechadv.2010.06.001
M3 - Review article
C2 - 20541598
AN - SCOPUS:77957021160
SN - 0734-9750
VL - 28
SP - 757
EP - 763
JO - Biotechnology Advances
JF - Biotechnology Advances
IS - 6
ER -